An independent advisory committee of the US Food and Drug Administration (FDA) supports the provision of emergency doses of Pfizer-BioNTech’s COVID-19 vaccine to children aged 5-11 years. Although younger children are thought to be less likely to become seriously ill or die from COVID-19, the FDA’s head of vaccines Dr. …
Read More »FDA Considers Pfizer’s COVID-19 Vaccine for Children
An independent advisory committee of the US Food and Drug Administration (FDA) met Tuesday (26/10) to consider approving emergency use of Pfizer-BioNTech’s COVID-19 vaccine for children ages 5-11. Although children are thought to rarely get seriously ill or die from COVID-19, the FDA’s head of vaccines Dr. Peter Marks Tuesday …
Read More »Pfizer’s COVID-19 Vaccine is 90 percent Effective in Preventing Hospitalization for Up to 6 Months
A new study has revealed that the two-dose COVID-19 vaccine made by Pfizer and BioNTech is 90 percent effective in keeping a person from being hospitalized for the virus for six months after receiving the second dose. Researchers from Pfizer and the US-based healthcare consortium Kaiser Permanente looked at the …
Read More »Pfizer’s 3rd Dose Boosts Immunity, But Current COVID-19 Vaccine is Still Effective
A review published Wednesday by the US Food and Drug Administration (FDA) found that a third dose of Pfizer’s COVID-19 vaccine boosts a person’s immunity to the virus. But the source added that current vaccines still provide sufficient protection to prevent severe illness. The FDA is considering Pfizer’s request to …
Read More »FDA Approves Pfizer’s COVID-19 Vaccine Booster Injection
The US Food and Drug Administration (FDA) has authorized the third injection of Pfizer-BioNTech’s COVID-19 vaccine for Americans 65 years of age and older and adults at high risk of serious illness. The result on Wednesday (22/9) also confirmed the injection of the booster (booster) for people in certain occupations …
Read More »